Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Terminated × lanreotide × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Carboplatin 9 Paclitaxel 8 Gemcitabine 8 Cisplatin 8 Cyclophosphamide 7 Fluorouracil 6 Docetaxel 5 Capecitabine 5 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Vinorelbine 3 Stem Cell Transplantation 3 Radiotherapy 3 Pemetrexed 3 Melphalan 3 Leucovorin 3 Filgrastim 3 Erlotinib Hydrochloride 3 Bone Marrow Transplantation 3 Bevacizumab 3 umbralisib 2 ublituximab 2 peginterferon alfa-2b 2 fludarabine 2 Whole-Body Irradiation 2 Trastuzumab 2 Transplantation, Homologous 2 Surveys and Questionnaires 2 S 1 (combination) 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02288377 2023-01-18

REMINET

Federation Francophone de Cancerologie Digestive

Phase 2/3 Terminated

53 enrolled 11 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡